198 related articles for article (PubMed ID: 12684426)
1. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.
Ikeda N; Nakajima Y; Tokuhara T; Hattori N; Sho M; Kanehiro H; Miyake M
Clin Cancer Res; 2003 Apr; 9(4):1503-8. PubMed ID: 12684426
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of aminopeptidase N in non-small cell lung cancer.
Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M
Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of angiogenesis in human pancreatic cancer.
Ikeda N; Adachi M; Taki T; Huang C; Hashida H; Takabayashi A; Sho M; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
Br J Cancer; 1999 Mar; 79(9-10):1553-63. PubMed ID: 10188906
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M
Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227
[TBL] [Abstract][Full Text] [Related]
5. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
6. Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
Murakami H; Yokoyama A; Kondo K; Nakanishi S; Kohno N; Miyake M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8674-9. PubMed ID: 16361553
[TBL] [Abstract][Full Text] [Related]
7. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) on the HL-60 cell line by TGF-beta(1).
Gabrilovac J; Breljak D; Cupić B
Int Immunopharmacol; 2008 May; 8(5):613-23. PubMed ID: 18387503
[TBL] [Abstract][Full Text] [Related]
8. cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo.
Buehler A; van Zandvoort MA; Stelt BJ; Hackeng TM; Schrans-Stassen BH; Bennaghmouch A; Hofstra L; Cleutjens JP; Duijvestijn A; Smeets MB; de Kleijn DP; Post MJ; de Muinck ED
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2681-7. PubMed ID: 16990557
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD13/aminopeptidase N on human gingival fibroblasts and up-regulation upon stimulation with interleukin-4 and interleukin-13.
Kunii R; Nemoto E; Kanaya S; Tsubahara T; Shimauchi H
J Periodontal Res; 2005 Apr; 40(2):138-46. PubMed ID: 15733148
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
[TBL] [Abstract][Full Text] [Related]
11. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
Loges S; Clausen H; Reichelt U; Bubenheim M; Erbersdobler A; Schurr P; Yekebas E; Schuch G; Izbicki J; Pantel K; Bokemeyer C; Fiedler W
Clin Cancer Res; 2007 Jan; 13(1):76-80. PubMed ID: 17200341
[TBL] [Abstract][Full Text] [Related]
12. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
[TBL] [Abstract][Full Text] [Related]
13. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer.
Hashida H; Takabayashi A; Kanai M; Adachi M; Kondo K; Kohno N; Yamaoka Y; Miyake M
Gastroenterology; 2002 Feb; 122(2):376-86. PubMed ID: 11832452
[TBL] [Abstract][Full Text] [Related]
14. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
15. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.
Harvey SR; Hurd TC; Markus G; Martinick MI; Penetrante RM; Tan D; Venkataraman P; DeSouza N; Sait SN; Driscoll DL; Gibbs JF
Clin Cancer Res; 2003 Oct; 9(13):4935-43. PubMed ID: 14581368
[TBL] [Abstract][Full Text] [Related]
17. Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis.
Fukasawa K; Fujii H; Saitoh Y; Koizumi K; Aozuka Y; Sekine K; Yamada M; Saiki I; Nishikawa K
Cancer Lett; 2006 Nov; 243(1):135-43. PubMed ID: 16466852
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Zhang Q; Wang J; Zhang H; Zhao D; Zhang Z; Zhang S
J Cancer Res Ther; 2015; 11(1):223-8. PubMed ID: 25879366
[TBL] [Abstract][Full Text] [Related]
19. Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis.
Inagaki Y; Tang W; Zhang L; Du G; Xu W; Kokudo N
Biosci Trends; 2010 Apr; 4(2):56-60. PubMed ID: 20448342
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of aminopeptidase N/CD13 in malignant melanoma.
Wulfänger J; Schneider H; Wild P; Ikenberg K; Rodolfo M; Rivoltini L; Meyer S; Riemann D; Seliger B
Carcinogenesis; 2012 Apr; 33(4):781-90. PubMed ID: 22307972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
